Healthcare -
Biotechnology - NASDAQ - US
$ 8.64
3.97 %
$ 74 M
Market Cap
-0.35
P/E
SRZN - OPERATING INCOME
Operating Income SRZN - Surrozen, Inc.
-25.5 M
LAST VALUE
24.11%
2 YEAR CAGR
-0.34%
5 YEAR CAGR
0.00%
10 YEAR CAGR